Immunoblotting results indicated that KEAP1 levels were downregulated, while NRF2 levels were increased to some extent in pancreatic cancer cells treated with kaempferol (Fig. 3b). This evidence concerns the gene NFE2L2 and familial pancreatic carcinoma.